PHE - Corporate - UKNSC Non-Invasive Prenatal Testing

The overall aim of the work is to apply the same methods used in a previous review, undertaken by Warwick University for the UK NSC, to review the evidence relating: 1 the accuracy of a new version of the technology (microarray) which was not available at the time of the previous review. This will inform a decision on whether Fetal Anomaly Screening Programme should include microarray technology in future procurement work 2 test accuracy for the detection T21, T18 and T13 in twins. At the time of the previous revie...